Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
The Bucket Report Icon
Trader's Guide 2024Ships December 21st. Download our December Market Report and reserve your copy today.
Date
Direction
Shares
Fund Weight
Fund
November 13, 2023
BUY106.152k0.0358%ARKK
November 10, 2023
BUY6.238k0.0022%ARKK
November 1, 2023
BUY21.751k0.009%ARKK
October 20, 2023
BUY29.319k0.0124%ARKK
October 19, 2023
BUY229.492k0.0967%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
2.9%$2.76b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
13🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
15$62.04
🎫ARK Ownership Percent
8.78%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA